Published in Ann Biomed Eng on March 18, 2006
Modeling of electric field distribution in tissues during electroporation. Biomed Eng Online (2013) 1.15
Kinetics of transmembrane transport of small molecules into electropermeabilized cells. Biophys J (2008) 1.10
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother (2015) 0.99
Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol (2010) 0.97
Effect of cell size and shape on single-cell electroporation. Anal Chem (2007) 0.97
Electropermeabilization of dense cell suspensions. Eur Biophys J (2007) 0.95
Cell electrofusion using nanosecond electric pulses. Sci Rep (2013) 0.93
Measuring the induced membrane voltage with Di-8-ANEPPS. J Vis Exp (2009) 0.90
Neuron matters: electric activation of neuronal tissue is dependent on the interaction between the neuron and the electric field. J Neuroeng Rehabil (2015) 0.81
Transmembrane potential induced on the internal organelle by a time-varying magnetic field: a model study. J Neuroeng Rehabil (2010) 0.80
"Classical" electropermeabilization modeling at the cell scale. J Math Biol (2012) 0.77
The Influence of Vesicle Shape and Medium Conductivity on Possible Electrofusion under a Pulsed Electric Field. PLoS One (2016) 0.77
A Microdosimetric Study of Electropulsation on Multiple Realistically Shaped Cells: Effect of Neighbours. J Membr Biol (2016) 0.77
Modeling of Transmembrane Potential in Realistic Multicellular Structures before Electroporation. Biophys J (2016) 0.76
Comparison between direct and reverse electroporation of cells in situ: a simulation study. Physiol Rep (2016) 0.76
Single-step electrical field strength screening to determine electroporation induced transmembrane transport parameters. Biochim Biophys Acta (2016) 0.76
Microfluidic Screening of Electric Fields for Electroporation. Sci Rep (2016) 0.76
Difference in Membrane Repair Capacity Between Cancer Cell Lines and a Normal Cell Line. J Membr Biol (2016) 0.75
Dependence of Electroporation Detection Threshold on Cell Radius: An Explanation to Observations Non Compatible with Schwan's Equation Model. J Membr Biol (2016) 0.75
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res (1995) 1.85
Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. Biophys J (2000) 1.59
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.55
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat (2011) 1.50
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res (2000) 1.19
Prognostic factors in the prediction of chronic wound healing by electrical stimulation. Med Biol Eng Comput (2001) 1.15
Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma (2007) 1.12
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res (2000) 1.11
Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer (1998) 1.10
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistry (2001) 0.98
Determination of the lipid bilayer breakdown voltage by means of linear rising signal. Bioelectrochemistry (2006) 0.97
Parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy in patients with peripheral vascular disease and in healthy volunteers. Ann Biomed Eng (2001) 0.96
Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett (1997) 0.95
Second-order model of membrane electric field induced by alternating external electric fields. IEEE Trans Biomed Eng (2000) 0.95
Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res (2000) 0.93
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry (2001) 0.93
Electric current density imaging of mice tumors. Magn Reson Med (1997) 0.92
Reproducibility of parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy and transcutaneous oximetry. Ann Biomed Eng (2000) 0.91
A reliable method of determining wound healing rate. Med Biol Eng Comput (2001) 0.89
Modelling of chronic wound healing dynamics. Med Biol Eng Comput (2000) 0.89
Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res (1998) 0.89
Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs (1998) 0.88
Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent. Biotechniques (2000) 0.87
Theoretical evaluation of the distributed power dissipation in biological cells exposed to electric fields. Bioelectromagnetics (2000) 0.86
Calculation of the electrical parameters in electrochemotherapy of solid tumours in mice. Comput Biol Med (1998) 0.86
The temperature effect during pulse application on cell membrane fluidity and permeabilization. Bioelectrochemistry (2008) 0.85
Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice--natural resistance and immune responsiveness. Anticancer Drugs (1996) 0.85
Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. Anticancer Res (1999) 0.84
Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images. J Microsc (2010) 0.84
Inhibition of SA-1 tumor growth in mice by human leukocyte interferon alpha combined with low-level direct current. Mol Biother (1990) 0.84
Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer (2001) 0.81
Effect of hydralazine on interstitial fluid pressure in experimental tumours and in normal tissue. In Vivo (2001) 0.80
An algorithm for synchronization of in vivo electroporation with ECG. J Med Eng Technol (2005) 0.79
Blood perfusion of subcutaneous tumours in mice following the application of low-level direct electric current. Adv Exp Med Biol (1999) 0.78
Modified cell proliferation due to electrical currents. Med Biol Eng Comput (1992) 0.77
Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett (1993) 0.77
Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma. Anticancer Drugs (1994) 0.75
Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors. Anticancer Drugs (1992) 0.75